Prader-Willi Syndrome Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Key Companies - Inversago, Saniona, OptiNose, Helsinn, Tonix Pharma, Neuren Pharma, ConSynance, GLWL Research

DelveInsight's "Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Prader-Willi Syndrome Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Prader-Willi Syndrome therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Prader-Willi Syndrome treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Prader-Willi Syndrome: An Overview
Prader-Willi syndrome (PWS) is characterized by severe hypotonia, poor appetite, and feeding difficulties in early infancy, followed in early childhood by excessive eating and gradual development of morbid obesity (unless food intake is strictly controlled). PWS is sometimes called Willi-Prader syndrome or Prader-Labhart-Willi syndrome.

The genes associated with PWS normally are expressed only from a region of chromosome 15 inherited from the father. The genes inherited from the mother normally are inactivated. Therefore, children affected with PWS have a deletion or disruption of the chromosome inherited from the father or have inherited two copies of this chromosomal region from the mother. The latter situation is called maternal uniparental disomy.

Prenatal diagnosis is possible in families with a previous history of PWS. Prior identification of a disease-causing abnormality can facilitate prenatal testing, but it is available by methylation analysis following amniocentesis regardless of course.

Treatment of a child affected with PWS involves the primary care physician and a multi-specialty team that includes an ophthalmologist to evaluate for myopia and strabismus, a pediatric endocrinologist for consideration of growth hormone treatment, and a developmental pediatrician.

Prader-Willi Syndrome Market Key Facts
• A study conducted by Gutierrz el al. (2023), to identify the etiology and epidemiology of Prader-Willi Syndrome, medical conditions, and emergencies estimated the prevalence of Prader-Willi Syndrome to be 1 in every 1 in 20000 to 1 in 30000 births.
• A study by Ragusa L. et al., (2020), quoted that approximately 65%-70% of the PWS cases are due to the deletion of paternal genes on chromosome 15 in the 15q11-q13 region, 20%-30% are caused by a maternal uniparental disomy of chromosome 15 and most of the remaining 2%-5% have an imprinting center defect or unbalanced translocations.

Discover How Prader-Willi Syndrome Market Will Grow by 2032:
https://www.delveinsight.com/report-store/prader-willi-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Prader-Willi Syndrome Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Prader-Willi Syndrome therapies in the market. It also provides a detailed assessment of the Prader-Willi Syndrome market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Prader-Willi Syndrome drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Prader-Willi Syndrome Epidemiology
The epidemiology section covers detailed insights into the historical, and current Prader-Willi Syndrome patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Prader-Willi Syndrome Epidemiology Segmented as -
• Total Prevalent Cases of Prader-Willi Syndrome (PWS) in the 7MM [2019-2032]
• Diagnosed Prevalent Cases of Prader-Willi Syndrome (PWS) in the 7MM [2019-2032]
• Mutation-specific Diagnosed Prevalent Cases of Prader-Willi Syndrome (PWS) in the 7MM [2019-2032]
• Treatable Cases of Prader-Willi Syndrome (PWS) in the 7MM [2019-2032]

Get Key Insights Into the Evolving Prader-Willi Syndrome Epidemiology Trends @
https://www.delveinsight.com/report-store/prader-willi-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Prader-Willi Syndrome Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prader-Willi Syndrome market or expected to be launched during the study period. The analysis covers the market share by Prader-Willi Syndrome drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Prader-Willi Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Prader-Willi Syndrome Therapeutics Assessment
Several major pharma and biotech companies are developing therapies for Prader-Willi Syndrome. Currently, Soleno Therapeutics is leading the therapeutics market with it's their Prader-Willi Syndrome drug candidates in the most advanced stage of clinical development.

Leading Companies in the Prader-Willi Syndrome Therapeutics Market Include
• Soleno Therapeutics
• Levo Therapeutics
• Inversago Pharma
• Saniona
• LG Life Sciences
• GLWL Research
• OptiNose
• Larimar Therapeutics
• Helsinn
• ConSynance Therapeutics
• Neuren Pharmaceuticals
• Radius Health
• Rhythm
• Tonix Pharmaceuticals
And Many Others

Emerging and Marketed Prader-Willi Syndrome Therapies Covered in the Report Include
• Diazoxide choline controlled release (DCCR): Soleno Therapeutics
• Intranasal carbetocin (LV-101): Levo Therapeutics
And Many More

Learn More About the Emerging Therapies & Key Companies in the Prader-Willi Syndrome Therapeutics Market:
https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Prader-Willi Syndrome Competitive Intelligence Analysis
4. Prader-Willi Syndrome Market Overview at a Glance
5. Prader-Willi Syndrome Background and Overview
6. Prader-Willi Syndrome Patient Journey
7. Prader-Willi Syndrome Epidemiology and Patient Population
8. Prader-Willi Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
9. Prader-Willi Syndrome Unmet Needs
10. Key Endpoints of Prader-Willi Syndrome Treatment
11. Prader-Willi Syndrome Marketed Products
12. Prader-Willi Syndrome Emerging Therapies
13. Prader-Willi Syndrome Seven Major Market Analysis
14. Attribute Analysis
15. Prader-Willi Syndrome Market Outlook (7 major markets)
16. Prader-Willi Syndrome Access and Reimbursement Overview
17. KOL Views on the Prader-Willi Syndrome Market.
18. Prader-Willi Syndrome Market Drivers
19. Prader-Willi Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/prader-willi-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Anti-hypertension Market
https://www.delveinsight.com/report-store/anti-hypertension-market

Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market

Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market

Cancer Cachexia (CC) Market
https://www.delveinsight.com/report-store/cancer-cachexia-cc-market-insights

Hepatitis C Market
https://www.delveinsight.com/report-store/hepatitis-c-market

Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Cerebral Infarction Market
https://www.delveinsight.com/report-store/cerebral-infarction-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Papilloma Market
https://www.delveinsight.com/report-store/papilloma-market

Peripheral Neuritis Market
https://www.delveinsight.com/report-store/peripheral-neuritis-market

Renal Insufficiency Market
https://www.delveinsight.com/report-store/renal-insufficiency-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

Persistent Depressive Disorder Market
https://www.delveinsight.com/report-store/persistent-depressive-disorder-market

Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market

Asthma Market
https://www.delveinsight.com/report-store/asthma-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Corneal Dystrophy Market
https://www.delveinsight.com/report-store/corneal-dystrophy-market

Peripheral Vascular Devices Global Market
https://www.delveinsight.com/report-store/peripheral-vascular-devices-market

Physiotherapy Equipment Market Concussions Market
https://www.delveinsight.com/report-store/concussions-market

Herpes Simplex Market
https://www.delveinsight.com/report-store/herpes-simplex-market

Hairy Cell Leukemia (HCL) Market
https://www.delveinsight.com/report-store/hairy-cell-leukemia-hcl-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.